Psychedelic substance Ibogaine to be tested for potential as an addiction treatment
9th December 2021 | By Emily Ledger It is estimated that around 100,000 people die from drug overdoses in the US every year. The [...]
As Addiction Deaths Surge, Profit-Driven Rehab Industry Faces ‘Severe Ethical Crisis’
February 15, 20217:08 AM ET Heard on Morning Edition As the nation's addiction crisis deepened, Tamara Beetham, who studies health policy at Yale University, set [...]
The Overdose Crisis: Interagency Proposal to Combat Illicit Fentanyl-Related Substances
View the hearing of the Subcommittee on Health, Committee on Energy and Commerce, U.S. House of RepresentativesChairwoman Eshoo, Ranking Member Guthrie, and members of the House [...]
People Living With HIV in New York State Faced Increased Burdens From COVID 19 in 2020
This study found that:In New York State, people living with HIV were more likely to be diagnosed with, hospitalized for, and die in hospital from [...]
Cooperation Between Physicians and Pharmacists May Improve Treatment for Patients with Opioid Use Disorder
These studies found that:Collaborations between physicians with buprenorphine waivers and community pharmacists in the treatment of patients with opioid use disorder (OUD) are feasible and [...]
DEA takes aggressive stance toward pharmacies trying to dispense addiction medicine
By Aneri Pattani | KHN Monday, November 8, 2021 Suboxone and a similar medicine, Subutex, are both proven to help people with opioid addiction [...]
Asymmetry in the Nucleus Accumbens May Be Linked with Substance Dependence
This study found that:People with some types of substance dependence exhibited less rightward asymmetry of the nucleus accumbens than did people without dependence. The reduced [...]
Media Briefing: NIH Leaders to speak at the Society for Neuroscience Annual Meeting about NIH COVID-19 research and the neurological implications of COVID-19
APA Style MLA Style AMA Style NIDA. 2021, November 1. Media Briefing: NIH Leaders to speak at the Society for Neuroscience Annual Meeting about NIH [...]
Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail
Joshua D. Lee, MD, MSc1,2; Mia Malone, BA1; Ryan McDonald, MA1; et alAnna Cheng, BA1; Kumar Vasudevan, MD1,2; Babak Tofighi, MD1,2; Ann Garment, MD2; Barbara Porter, MD2; Keith S. Goldfeld, DrPH1; Michael Matteo3; Jasdeep Mangat, MD3; Monica Katyal, JD, MPH3; Jonathan Giftos, MD3; Ross MacDonald, MD2,3 Author Affiliations Article Information JAMA Netw Open. 2021;4(9):e2123032. doi:10.1001/jamanetworkopen.2021.23032 Key Points Question Is extended-release buprenorphine an acceptable and helpful jail-to-community treatment [...]
Trends in and Characteristics of Buprenorphine Misuse Among Adults in the US
October 15, 2021 Beth Han, MD, PhD, MPH1; Christopher M. Jones, PharmD, DrPH, MPH2; Emily B. Einstein, PhD1; et alWilson M. Compton, MD, MPE1 Author Affiliations Article Information JAMA Netw Open. 2021;4(10):e2129409. doi:10.1001/jamanetworkopen.2021.29409 Key Points Question With recent increases in [...]